Evaluation of the antiemetic effect of Valeriana officinalis root extract in young chicken

Journal of Medicinal Plants

Volumn 10, Issue 38, 2011, Pages 127-134

  Hosseinzadeh, H ^a,c   Jaafari, M R ^b   Parhiz, B H ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antiemetic; Antivomiting; Copper sulfate; Emesis; Ipecac; Valeriana officinalis; Young chicken

Indexed keywords

COPPER SULFATE; IPECAC; VALERIAN;

ANIMAL EXPERIMENT; ANTIEMETIC ACTIVITY; ARTICLE; CHICKEN; CONTROLLED STUDY; DRUG SCREENING; NONHUMAN; PLANT ROOT; VALERIANA OFFICINALIS; VOMITING;

CEPHAELIS IPECACUANHA; VALERIANA; VALERIANA OFFICINALIS;

EID: 80053272856     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Herrstedt J. Nausea and emesis: still an unsolved problem in cancer patients? Support Care Cancer 2002; 10: 85-7. (Pubitemid 36056304)
2. th ed. Tehran University Press. Iran. 1998, Vol. 2, pp: 752-63.
3. st ed. Ministry of Health and Medical Education. Iran. 2003, Vol. 2, pp: 456-63.
4. nd ed. 2002, pp: 1007-31.
5. st ed. Islamic Culture Press. Iran. 1993, Vol. 3, pp: 187-92.
6. Cropley M, Cave Z, Ellis J, and Middleton RW. Effect of kava and valerian on human physiological responses to mental stress assessed under laboratory conditions. Phytother. Res. 2002; 16: 23-7. (Pubitemid 34116690)
7. Jacobs BP, Bent S, Tice JA, Blackwell T and Cummings SR. An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. Medicine 2005; 8: 197-207. (Pubitemid 41026294)
8. Fields AM Richards TA, Felton JA, Felton SK, Bayer EZ, Ibrahim IN and Kaye AD. Analysis of responses to valerian root extract in the feline pulmonary vascular bed. J. Altern. Complement. Med. 2003; 9: 909-18. (Pubitemid 38049707)
9. Si XY, Jia RH, Huang CX, Ding GH and Lin, HY. Effects of Valeriana officinalis var.latifolia on expression of transforming growth factor beta 1 in hypercholesteromic rats. Zhongguo. Zhong. Yao. Za. Zhi. 2003; 28: 845-48.
10. th ed. Rockvill: The united states pharmacopeial convention. USA. 2002, pp: 2638-40.
11. Boyadzhiev L, Kancheva D, Gourdon C and Metcheva D. Extraction of valerenic acids from valerian (Valeriana officinalis L.) rhizomes. Pharmazie 2004; 59: 727-28. (Pubitemid 39281016)
12. Hosseinzadeh H, Ramezani M and Naghizadeh B. Antiemetic effect of Mentha longifolia aerial parts extracts and fractions in young chickens. Iran J. Basic Med. Sci. 2004; 7: 145-50.
13. European Scientific Cooperative on Phytotherapy. Escope Monographs. 2nd ed. Thieme. USA. 2003, pp: 539-45.
14. Hui-Lian W, Dong-Fang Z, Zhao-Feng L, Yang L, Qian-Rong L and Yu-Zhen W. In vitro study on the genotoxicity of dichloromethane extracts of valerian (DEV) in human endothelial ECV 304 cells and the effect of vitamins E and C in attenuing the DEV-induced DNA damages. Tox. Applied Pharm. 2003; 188: 36-41. (Pubitemid 36369387)
15. Galati G and J.o P. Serial review: flavonoids and isoflavones (phytoestrogens): absorption, metabolism, and bioactivity. Free Radical Biol. Med. 2004; 37: 287-303.
16. Prasanthi K, Rajini RS. Morphological and biochemical perturbations in rat erythrocytes following in vitro exposure to fenvalerate and its metabolite. Toxicol. In Vitro. 2005; 19: 449-56.
17. Kawabe M, Tamano S, Shibata MA, Hirose M, Fukushima S and Ito N. Subchronic toxicity study of methyl hesperidine in mice. Toxicol. Letter. 1993; 69: 37-44.
18. Kosnett MJ. Lead In: Ford MD, Delaney KA, Ling LJ and Erickson T. Clinical Toxicol. W.B. Saunders Company. USA. 2001, pp: 723-36.
19. Abraham A, Sridhar N and Veeranjaneyulu A. Cancer chemotherapy and radiation induced emesis (CRIE): current and future therapeutic approaches. Ind. J. Pharmacol. 2000; 32: 256-68.
20. th ed. McGraw Hill. USA. 2001, pp: 1029-33.
21. Hazelhoff B, Malingre TM and Meijer DK. Antispasmodic effects of Valeriana compounds: an in vivo and in vitro study on the guinea-pig ileum. Arch. Int. Pharmacodyn. Ther. 1982; 257: 274-87. (Pubitemid 12073467)
22. Mandala M, Cremonesi M, Rocca A, Cazzaniga M, Ferretti G, Di Cosimo S, Ghilardi M, Cabiddue M and Bami S. Midazolam for acute emesis refractory to dexamethasone and granisetron after highly emetogenic chemotherapy: a phase II study. Support Care Cancer. 2005; 13: 375-80. (Pubitemid 40922355)
23. Santos MS, Ferrela F, Cunha AP, Carvalho AP, Ribeiro CF and Macedo T. Synaptosomal GABA release as influenced by valerian root extract - involvement of the GABA carrier. Arch. Int. Pharm. Ther. 1994; 327: 220-31. (Pubitemid 24224673)
24. Houghton PJ. The scientific basis for the reputed activity of valerian. J. Pharm. Pharmacol. 1999; 51: 505-12. (Pubitemid 29319774)
25. Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie, JT and Ang-Lee MK. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth. Analg. 2004; 98: 353-8. (Pubitemid 38129379)
26. Micklus MJ, Greig NH, Tuny J and Rapoport SI. Organ distribution of liposomal formulation following intracarotid infusion in rats. Biochemica. et Biophysica. Acta. 1992; 1124: 7-12.
27. Marder M, Viola H, Wasowski C, Fernandez S, Medina JH and Paladini AC. 6-Methylapigenin and hesperidin : new Valeriana flavonoids with activity on the CNS. Pharmacol. Biochem. Behave. 2003; 75: 537-45. (Pubitemid 36936888)
28. 21 receptors. Biochem. Pharmacol. 2005; 69: 1101-11.